Navigation Links
Salugen's Award-Winning Research on Using DNA Information to Customize Nutritional Supplementation for Weight Loss Presented at the Second Annual Bruce Ames International Symposium on Nutritional Genomics at the University of California, Davis
Date:10/26/2007

SAN DIEGO, Oct. 26 /PRNewswire/ -- Salugen, Inc., a personalized health and wellness company presented its research entitled: DNA-customized Genotrim [neuronal dopamine release activator] results in significant reductions in weight, appetite and sugar cravings in an obese population in the Dietary Investigation to Evaluate Treatments (D.I.E.T.) pilot study. Polymorphic gene correlates of Reward Deficiency Syndrome (RDS) at the Second Bruce Ames International Symposium on Nutritional Genomics last week at the University of California, Davis. Over the past two years, Salugen's research around genetics and weight loss has been repeatedly awarded by the nation's largest natural products association. At this meeting, Dr. Kenneth Blum, Chief Scientific Officer of Salugen discussed the nutrigenomics of weight loss, specifically on identifying the genes and nutrients governing cravings and appetite.

According to Dr. Kenneth Blum, the co-discoverer of the gene associated with alcoholism, "This study demonstrates that GenoTrim, a DNA-customized nutritional supplement for weight management, is a potentially effective agent in reducing weight and improving symptomatic RDS behaviors. We are also proposing that for persons possessing candidate reward gene polymorphisms resulting in physiological deficits in brain reward neurotransmitters, utilizing a dopaminergic type d2 receptor agonist, such as GenoTrim, can activate the neuronal release of dopamine in the nucleus acumbens."

In this study over 80 days, GenoTrim demonstrated significant reductions in weight, waist circumference, appetite, and sugar cravings, as well as improvements in energy, and feelings of happiness.

Salugen CEO Brian Meshkin states, "We are honored to be among so many other credible researchers from around the world to present important findings about the use of genetic information to customize nutritional supplementation that demonstrates weight loss and improved health. This study adds to over 10 scientific publications supporting GenoTrim for DNA-customized weight loss. We congratulate the staff at UC Davis for a wonderful conference."

Salugen currently markets DNA-customized nutritional solutions under three brands, GenoTrim(TM) for weight management (http://www.GenoTrim.com), SpaGen(TM) for optimal health and wellness (http://www.SpaGen.com) and Haveos(TM) for substance abuse attenuation.

About Salugen

Salugen, Inc., a leading personalized health and wellness company, engages in the discovery, development and commercialization of patent-protected genetic tests and companion DNA-customized therapeutics worldwide. With over 30 years of research conducted on the genetic causes and pharmacology of many healthcare concerns, Salugen is a pioneer and leader in delivering personalized medicine. Currently, the Company commercializes nutrigenomic technologies where genetic analysis guides the formulation and delivery of nutritional solutions that are customized to the individual. The company has headquarters in San Diego, CA, with its high-complexity CLIA-certified laboratory services in Los Angeles, CA. For additional information about the company, please visit http://www.salugen.com.


'/>"/>
SOURCE Salugen, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. UW-Madison engineers apply award-winning technology to road building
2. Sprecher Brewing unveils award-winning digital office
3. The DIG System Nonradioactive Automated High-Throughput In Situ Hybridization: a Powerful Tool for Functional Genomics Research
4. Quantitation of the Protein MIA as a Marker for Chondrocytes in Research Samples
5. Control Your siRNA Research
6. Getting Started with MicroRNA Research
7. Monitoring Microbial Populations Using Real-Time qPCR on the MJ Research Opticon 2 System
8. Proteomics in Bladder Cancer Research: Protein Profiling of Bladder Squamous Cell Carcinomas, Rev C
9. Research Organics
10. A Robust LC/MS/MS Method for the Quantitation of Very Long Chain Fatty Acids for Research into the Characterization of Peroxisomal Disorders
11. A new LC/MS/MS Research Method for Rapid Quantitation of Five Immunosuppressant Drugs, including Mycophenolic Acid (MPA)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... Pa., Feb. 24, 2017  VWR Corporation (NASDAQ: VWR), the ... laboratory and production customers, today reported its financial results for ... Highlights: 4Q16 record quarterly ... 1.0% on an organic basis. ... an organic basis, while the Americas net sales increased 2.5%, ...
(Date:2/23/2017)... LONDON and NEW YORK ... at HIMSS, Lumeon , a leading digital ... (DN Telehealth), a provider of telemedicine and remote ... care pathways for telemedicine reimbursements.  ... and their patients, in real-time, extending consultations beyond ...
(Date:2/23/2017)... (PRWEB) , ... February 23, 2017 , ... ... Drug Discovery Services portfolio to include an array of biochemical analyses critical ... reliable data to drive their hit-to-lead and SAR programs, including inhibitor potency and ...
(Date:2/23/2017)... 2017  MIODx announced today that it has ... technologies from the University of California, San Francisco ... monitor a patient for response to immune checkpoint ... second license extends the technology with a method ... have an immune-related adverse event (IRAE) from their ...
Breaking Biology Technology:
(Date:2/8/2017)... Feb. 7, 2017 Report Highlights ... The global synthetic-biology market ... billion by 2021, growing at a compound annual growth rate ... overview of the global markets for synthetic biology. - Analyses ... 2016, and projections of compound annual growth rates (CAGRs) through ...
(Date:2/7/2017)... BEACH, New York , February 7, 2017 /PRNewswire/ ... known as ID Global Solutions Corporation [OTC: IDGS], ("Ipsidy" ... identity management and electronic transaction processing services, is pleased ... reorganization of the Company. Effective January 31, ... of the Board of Directors, CEO and President.  An ...
(Date:2/2/2017)... , Feb. 2, 2017  EyeLock LLC, a ... a new white paper " What You Should Know ... problem of ensuring user authenticity is a growing concern. ... authentication of users. However, traditional authentication schemes such as ... Biometric authentication offers an elegant solution to ...
Breaking Biology News(10 mins):